subscribe
 

Developing treatment for debilitating rare disease

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita



Subscribe

Subscribe



Newsbrief

Twitter Icon © Setform Limited
subscribe